A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy
Clinical trial NCT04063215 · COMPLETED
Trial details
- NCT number
- NCT04063215
- Sponsor
- Hope Biosciences LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-01
- Primary completion
- 2024-10-25
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.